Experiencenew
Branding & Naming Experience
Brand Institute excels as the global leader in brand name and identity development, spanning healthcare, consumer products, and pharmaceutical standards. With over 75% of drug name approvals globally and unparalleled success in consumer and business-to-business branding, it sets the industry benchmark. Additionally, it dominates USAN/INN naming, with significant majorities in drug name approvals worldwide.
1,456
Healthcare Clients
4,777
Total Healthcare Names
1,621
USAN/INN (Nonproprietary)
456
Consumer/B2B Clients
980
Total Consumer/B2B Names
94
Corporate Identities
General Search
Showing 1 - 10 out of 21
Brand | Client | Service | Category |
---|---|---|---|
Xtandi | Astellas / Pfizer | ||
Paxlovid | Pfizer | ||
Avastin | Genentech | ||
Leqembi | Eisai / Biogen | ||
Rybelsus | Novo Nordisk | ||
Bimzelx | UCB | ||
Tezspire | Amgen / AstraZeneca | ||
Lunesta | Waylis Therapeutics | ||
Caplyta | Intra-Cellular Therapies | ||
Hemlibra | Genentech |